อาโมจิน โคเมด
AMOGIN KOMED
activeLast updated: 2026-07-29
Product & certifications 2
- FDA 1A748/68(E)drugคงอยู่
- FDA 1A78/68drugคงอยู่
ตัวยาสำคัญ
- OMEPRAZOLE PELLETS 8.5% W/W235.294 milligramต่อ 1 capsule
- ประเภทควบคุม
- ยาอันตราย
- ข้อบ่งใช้
- Adults - Treatment of duodenal ulcers - Prevention of relapse of duodenal ulcers - Treatment of gastric ulcers - Prevention of relapse of gastric ulcers - In combination with appropriate antibiotics, Helicobacter pylori (H. pylori) eradication in peptic ulcer disease - Treatment of NSAID-associated gastric and duodenal ulcers - Prevention of NSAID-associated gastric and duodenal ulcers in patients at risk - Treatment of reflux oesophagitis - Long-term management of patients with healed reflux oesophagitis - Treatment of symptomatic gastro-oesophageal reflux disease - Treatment of Zollinger-Ellison syndrome Pediatric use Children over 1 year of age and > 10 kg - Treatment of reflux oesophagitis - Symptomatic treatment of heartburn and acid regurgitation in gastro-oesophageal reflux disease Children and adolescents over 4 years of age - In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori
- รหัส ATC
- A02BC01 (omeprazole)
ข้อมูลตามที่ขึ้นทะเบียนกับ อย. — ไม่ใช่คำแนะนำการใช้ยา ปรึกษาเภสัชกรหรือแพทย์ก่อนใช้เสมอ
- Category
- ยาสำเร็จรูป
- Trade name
- —
- Company / Manufacturer
- บริษัท มิลลิเมด บีเอฟเอส จำกัดดำเนินกิจการ
- Juristic registration number
- 0575558000029
- Producer's other permits
- See all permits held by this company →
A matching registration number confirms the registration exists — it does not verify that the physical item you hold is genuine. Always compare the product and manufacturer names on the label.
Last updated: 2026-07-29 · Data aggregated from official government databases: NBTC · FDA · TISI · DBD · Dept. of Tourism · ACFSReport incorrect data